Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease.

Abstract excerpt

BACKGROUND & AIMS: Autosomal recessive polycystic kidney disease (ARPKD) is caused by mutations in PKHD1, encoding fibrocystin/polyductin (FPC). Severe disease occurs in perinates. Those who survive the neonatal period face a myriad of comorbidities, including systemic and portal hypertension, liver fibrosis, and hepatosplenomegaly. The goal here was to uncover therapeutic strategies for ARPKD. METHODS: We used...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cystic Fibrosis Transmembrane Conductance Regulator
• Share to Endoplasmic Reticulum-Associated Degradation